Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Sievers

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Brain Pathology (Zurich, Switzerland)|June 22, 2023
A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytomaArnault Tauziède-Espariat, Kévin Beccaria, Volodia Dangouloff-Ros, et al.
Acta Neuropathologica Communications|August 21, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Acta Neuropathologica|November 16, 2019
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutationPhilipp Sievers, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|October 23, 2023
PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumorsArnault Tauziède-Espariat, Aurore Siegfried, Yvan Nicaise, et al.
Neuro-Oncology Advances|February 27, 2026
A Cre-mediated copy number variant compromises the reliability of a <i>LoxP-STOP-LoxP</i>-<i>PLAG1</i> driven brain tumor modelJan Vaillant, Sangita Pal, Jan Müller, et al.
Acta Neuropathologica Communications|February 4, 2021
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activationAndrey Korshunov, Konstantin Okonechnikov, Felix Schmitt-Hoffner, et al.
Neuro-Oncology|February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningiomaFranziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
Pediatric Blood & Cancer|November 6, 2024
Soft Tissue Undifferentiated Sarcoma Carrying a Novel Onecut1::Nutm1 FusionMaria Filippidou, Stavros Glentis, Efthymia Rigatou, et al.
Acta Neuropathologica Communications|May 24, 2025
Glioneuronal tumors PATZ1-fused: clinico-molecular and DNA methylation signatures for a variety of morphological and radiological profilesArnault Tauziède-Espariat, Volodia Dangouloff-Ros, Philipp Sievers, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica Communications|January 6, 2025
Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Brain Pathology (Zurich, Switzerland)|June 22, 2023
A comprehensive analysis of infantile central nervous system tumors to improve distinctive criteria for infant-type hemispheric glioma versus desmoplastic infantile ganglioglioma/astrocytomaArnault Tauziède-Espariat, Kévin Beccaria, Volodia Dangouloff-Ros, et al.
Acta Neuropathologica Communications|August 21, 2025
Correction: Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profilingKonstantin Okonechnikov, David R Ghasemi, Daniel Schrimpf, et al.
Acta Neuropathologica|November 16, 2019
Posterior fossa pilocytic astrocytomas with oligodendroglial features show frequent FGFR1 activation via fusion or mutationPhilipp Sievers, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|October 23, 2023
PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tumorsArnault Tauziède-Espariat, Aurore Siegfried, Yvan Nicaise, et al.
Neuro-Oncology Advances|February 27, 2026
A Cre-mediated copy number variant compromises the reliability of a <i>LoxP-STOP-LoxP</i>-<i>PLAG1</i> driven brain tumor modelJan Vaillant, Sangita Pal, Jan Müller, et al.
Acta Neuropathologica Communications|February 4, 2021
Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activationAndrey Korshunov, Konstantin Okonechnikov, Felix Schmitt-Hoffner, et al.
Neuro-Oncology|February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningiomaFranziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
Pediatric Blood & Cancer|November 6, 2024
Soft Tissue Undifferentiated Sarcoma Carrying a Novel Onecut1::Nutm1 FusionMaria Filippidou, Stavros Glentis, Efthymia Rigatou, et al.
Acta Neuropathologica Communications|May 24, 2025
Glioneuronal tumors PATZ1-fused: clinico-molecular and DNA methylation signatures for a variety of morphological and radiological profilesArnault Tauziède-Espariat, Volodia Dangouloff-Ros, Philipp Sievers, et al.
Pageof 13